Nuwellis (NUWE) EBIT Growth (5y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Nuwellis | 1.45 Mn | -630,292.49 | 1.68 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.63% |
| Dec 31, 2025 | -17.71% |
| Sep 30, 2025 | 8.72% |
| Jun 30, 2025 | 5.81% |
| Mar 31, 2025 | 7.70% |
| Dec 31, 2024 | 11.70% |
| Sep 30, 2024 | 19.41% |
| Jun 30, 2024 | 12.13% |
| Mar 31, 2024 | -0.10% |
| Dec 31, 2023 | 3.32% |
| Sep 30, 2023 | 5.73% |
| Jun 30, 2023 | -3.74% |
| Mar 31, 2023 | -6.09% |
| Dec 31, 2022 | 27.30% |
| Sep 30, 2022 | -6.49% |
| Jun 30, 2022 | -11.47% |
| Mar 31, 2022 | -13.86% |
| Dec 31, 2021 | -21.06% |
| Sep 30, 2021 | -5.27% |
| Jun 30, 2021 | -3.49% |
| Mar 31, 2021 | -2.76% |
| Dec 31, 2020 | 28.34% |
| Sep 30, 2020 | 7.46% |
| Jun 30, 2020 | 9.17% |
| Mar 31, 2020 | 8.17% |
| Dec 31, 2019 | -19.43% |
| Sep 30, 2019 | 5.90% |
| Jun 30, 2019 | 7.83% |
| Mar 31, 2019 | 5.78% |
| Dec 31, 2018 | 9.47% |
| Sep 30, 2018 | 7.20% |
| Jun 30, 2018 | 4.64% |
| Mar 31, 2018 | 0.22% |
| Dec 31, 2017 | -11.69% |
| Sep 30, 2017 | 2.78% |
| Jun 30, 2017 | 5.73% |
| Mar 31, 2017 | 10.88% |
| Dec 31, 2016 | 27.29% |
| Sep 30, 2016 | 2.89% |
| Jun 30, 2016 | -2.31% |
| Mar 31, 2016 | -9.20% |